MEIL Lays Foundation Stone For Young India Skills University
HYDERABAD, India, Nov. 8, 2024 /PRNewswire/ — Megha Engineering & Infrastructures Limited (MEIL) marked a momentous occasion on Friday, November 8, 2024, with the laying of the foundation stone for the Young India Skills University buildings at Net Zero Valley, Meerkhanpet, Kandukur Mandal
Acer Announces Consolidated Revenues for October at NT$18.82 Billion, Year-to-October at NT$217.41 Billion with 10.1% Growth
TAIPEI, Nov. 8, 2024 /PRNewswire/ — Acer Inc. (TWSE: 2353) announced its consolidated revenues for October at NT$18.82 billion, and for year-to-October at NT$217.41 billion with 10.1% growth year-on-year (YoY), while revenues from the personal computers[1] and display business grew 9.3% YoY ye
Global Times: Sporting the beauty of traditional legacies and design innovation
BEIJING, Nov. 8, 2024 /PRNewswire/ — The sense of beauty has intrigued humanity since the dawn of civilization. Various ancient cultures have developed their own recognizable aesthetics. Among these, Chinese aesthetics has its own unique school of thought. Today, a fresh wave of neo-Chinese ae
Halfaya Oilfield employee shines through in his commitment to safety
BEIJING, Nov. 8, 2024 /PRNewswire/ — A news report from chinadaily.com.cn： At CNPC’s Halfaya Oilfield, Feng Jianxun, manager of the HSE department, has dedicated himself to ensuring the safe and efficient progress of the project. His day begins with routine visits and continuous spot
Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
The submission is supported by data from the pivotal WU-KONG1 Part B study, which featured in an oral session at the 2024 ASCO Annual Meeting Sunvozertinib is the world’s first and only oral drug approved for NSCLC patients with EGFR exon20ins SHANGHAI, Nov. 8, 2024 /PRNewswire/ — Dizal
ASSAÍ: REVENUE REACHES R$ 20 BILLION IN THE QUARTER, LEVERAGE CONTINUES TO DECLINE
SÃO PAULO, Nov. 8, 2024 /PRNewswire/ — Assaí Atacadista (ASAI) reported solid results for the third quarter of 2024, with revenue reaching R$ 20.2 billion, a 9.3% year-over-year growth, reflecting the maturation of its expansion strategy and continued strengthening of its customer base. Focu
ZKH Group Limited to Announce Third Quarter 2024 Financial Results on Friday, November 22, 2024
SHANGHAI, Nov. 8, 2024 /PRNewswire/ — ZKH Group Limited (“ZKH” or the “Company”) (NYSE: ZKH), a leading maintenance, repair and operations (“MRO”) procurement service platform in China, today announced that it will release its unaudited financial results for
Global Times: World Conference of Classics creates new platform for mutual learning
BEIJING, Nov. 8, 2024 /PRNewswire/ — Chinese President Xi Jinping sent a congratulatory letter on Thursday to the World Conference of Classics. With the theme “Classical Civilizations and the Modern World,” the conference opened in Beijing on the same day. Xi noted that the confe
Nansha Shines at CIIE: Converging at the Bay, Connecting to the World
SHANGHAI, Nov. 8, 2024 /PRNewswire/ — This is a news release from Nansha Economic and Technological Development Zone Commerce Bureau, Guangzhou: From November 5 to 10, 2024, the 7th China International Import Expo (CIIE) is being held as scheduled at the National Exhibition and Convention C
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 8, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncolog
